Kalorama Information Publishes Molecular Diagnostics Market Update
New York, NY (PRWEB) February 12, 2014 -- Kalorama Information has published “Molecular Diagnostics Six Month Update,” the latest look at this fast-growing IVD test segment.
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December. This report highlights trends and developments that portent the evolution of molecular tests and technologies. The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.
Though focused on the developments of the last six months, coverage is substantial. As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:
• Microbiology
• Histology
• Blood Screening
• Prenatal
• Coagulation
• Inherited Diseases
• Tissue Typing
• Cancer Markers
• Pharmacodiagnostics
• CTCs
The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations. In addition the following important trend information is also provided:
• Selected Sequencing-Based Innovations July-December 2013
• Selected Molecular Diagnostics Collaborations, July-December 2013
• Selected Molecular Diagnostics Licensing Agreements, July-December 2013
• Selected Molecular Diagnostics Distribution Agreements, July-December 2013
• Regulatory and Reimbursement Update
• Molecular Test Revenues of The Top Companies, 2012-2013
Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.
“The Molecular Diagnostics Six Month Update” is available at http://www.kaloramainformation.com/Molecular-Diagnostics-Month-7969379/.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
Bruce Carlson, Kalorama Information, http://home.kaloramainformation.com/, (212) 807-2622, [email protected]
Share this article